Adaptimmune Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-New Enterprise Associates 14, L.P.(6.7%),NEA Partners 14, L.P.(6.7%)等
04/03 08:41
Adaptimmune Therapeutics | 3:首次持股声明-股东 EcoR1 Capital, LLC
03/27 00:04
Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%)等
03/27 00:04
Adaptimmune Therapeutics | 4:持股变动声明-高管 Piccina Cintia
03/19 05:01
Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%)等
02/15 06:49
Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%)等
02/15 06:11
Adaptimmune Therapeutics | SC 13G:超过5%持股股东披露文件-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%)等
01/31 06:29
Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baillie Gifford & Co (Scottish partnership)(7.01%)
01/30 00:53
Adaptimmune Therapeutics | 4:持股变动声明-高管 Rawcliffe Adrian
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 Bertrand William C JR
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 Lunger John
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 Norry Elliot
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-董事 Behbahani Ali
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 Bertrand William C JR
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-董事 Hege Kristen
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 Lunger John
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 Brewer Joanna Elizabeth
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 TAYTON-MARTIN HELEN KATRINA
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 Rawcliffe Adrian
01/17 13:00
Adaptimmune Therapeutics | 4:持股变动声明-高管 Norry Elliot
01/17 13:00
暂无数据
暂无数据